Strata Oncology Announces Publication of Study Validating Clinical Utility of Pan-tumor Predictive Biomarker for Checkpoint Inhibitor Immunotherapy Benefit
/PRNewswire/ -- Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced the...
Source: prnewswire.com